Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma

  • Srividya Kotapati, Ying Zhang, T. Kim Le, James Shaw
  • ClinicoEconomics and Outcomes Research, July 2015, Dove Medical Press
  • DOI: 10.2147/ceor.s78704

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Ms Ying Zhang